Form D · Pharmaceuticals
Encore Vision, Inc.
Fort Worth, TX · CIK 0001618596
Offering snapshot reported May 13, 2016 · SEC filing
- Reported sold
- $4.5M Offering amount: $4.5M
- Investors reported
- 48 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 21, 2015 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$2,500,000 → $4,500,000
- Reported investors34 → 48
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 13, 2016 | Amendment | $4,500,000 | $2,000,000vs Aug 25, 2015 | 48 | SEC filing |
| Aug 25, 2015 | Initial | $2,500,000 | No comparison | 34 | SEC filing |
| Feb 9, 2015 | Initial | $1,116,224 | No comparison | 22 | SEC filing |
| Sep 17, 2014 | Initial | $1,680,106 | No comparison | 29 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-246414
Series C Preferred Stock
Source: Form D, filed May 13, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Peter Bennett | Director |
| Evelyn Blake | Executive |
| William R. Burns | Director, Executive |
| Adrienne Graves | Director |
| John Hunkeler | Director |
| Les Kreis | Director |
| Les Kries | Director |
| Richard Lindstrom | Director |
| William Ed Tyler | Director |
| Robert Willard | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1120 South Freeway, Suite 118
Fort Worth, TX, 76104
Fort Worth, TX, 76104